Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Darbepoetin Alfa Administered Once Every Four Weeks in Chronic Renal Insufficiency (CRI) Subjects With Anemia

NCT00527215 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00527215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00527215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Darbepoetin Alfa Administered Once Every Four Weeks in Chronic Renal Insufficiency (CRI) Subjects With Anemia
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2002
Completion date
October 31, 2003
Enrollment
98 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pre-dialysis